ReviewiScience2025
Capsule neural network and its applications in drug discovery.
Review in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deep learning holds great promise in drug discovery, yet its application is hindered by high labeling costs and limited datasets. Developing algorithms that effectively learn from sparsely labeled data is crucial. Capsule networks (CapsNet), introduced in 2017, solve the spatial information loss in traditional neural networks and excel in handling small datasets by capturing spatial hierarchical relationships among features. This capability makes CapsNet particularly promising for drug discovery, where data scarcity is a common challenge. Various modified CapsNet architectures have been successfully applied to drug design and discovery tasks. This review provides a comprehensive analysis of CapsNet's theoretical foundations, its current applications in drug discovery, and its performance in addressing key challenges in the field. Additionally, the study highlights the limitations of CapsNet and outlines potential future research directions to further enhance its utility in drug discovery, offering valuable insights for researchers in both computational and pharmaceutical sciences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.